Home/Filings/4/0001019687-16-005812
4//SEC Filing

CV Sciences, Inc. 4

Accession 0001019687-16-005812

$CVSICIK 0001510964operating

Filed

Apr 10, 8:00 PM ET

Accepted

Apr 11, 7:15 PM ET

Size

18.7 KB

Accession

0001019687-16-005812

Insider Transaction Report

Form 4
Period: 2016-02-28
Mai Dun Ltd LLC
10% OwnerOther
Transactions
  • Other

    Common Stock

    2016-02-281,600,0000 total
Holdings
  • Common Stock

    (indirect: See footnote)
    5,408,530
  • Common Stock

    5,463,162
  • Common Stock

    618,564
  • Common Stock

    75,000
  • Common Stock

    (indirect: See footnote)
    6,081,726
Transactions
  • Other

    Common Stock

    2016-02-281,600,0000 total
Holdings
  • Common Stock

    5,463,162
  • Common Stock

    618,564
  • Common Stock

    75,000
  • Common Stock

    (indirect: See footnote)
    5,408,530
  • Common Stock

    (indirect: See footnote)
    6,081,726
Transactions
  • Other

    Common Stock

    2016-02-281,600,0000 total
Holdings
  • Common Stock

    75,000
  • Common Stock

    5,463,162
  • Common Stock

    618,564
  • Common Stock

    (indirect: See footnote)
    6,081,726
  • Common Stock

    (indirect: See footnote)
    5,408,530
Transactions
  • Other

    Common Stock

    2016-02-281,600,0000 total
Holdings
  • Common Stock

    (indirect: See footnote)
    6,081,726
  • Common Stock

    75,000
  • Common Stock

    5,463,162
  • Common Stock

    618,564
  • Common Stock

    (indirect: See footnote)
    5,408,530
Transactions
  • Other

    Common Stock

    2016-02-281,600,0000 total
Holdings
  • Common Stock

    5,463,162
  • Common Stock

    (indirect: See footnote)
    5,408,530
  • Common Stock

    75,000
  • Common Stock

    618,564
  • Common Stock

    (indirect: See footnote)
    6,081,726
Footnotes (7)
  • [F1]On February 28, 2016, Roen Ventures LLC ("Roen Ventures") transferred and assigned 1,600,000 shares of the Issuer's common stock to Far West Industries ("Far West") pursuant to that certain Settlement Agreement, dated September 10, 2015, by and between Roen Ventures and Far West. No cash consideration was paid by Far West for the transfer of the shares. The shares were transferred in consideration of the release of all claims against Roen Ventures by Far West. The closing price per share as quoted on the OTC Bulletin Board on September 10, 2015 was $0.90.
  • [F2]No securities of the Issuer are directly owned by Roen Ventures, who is a member of a "group" with Mai Dun Limited LLC ("Mai Dun"), Mercia Holdings LLC ("Mercia"), Mackay Ventures LLC ("Mackay Ventures") and Bart Mackay ("Mr. Mackay") for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended ("Exchange Act").
  • [F3]The securities are directly owned by Mr. Mackay, who is a member of a "group" with Roen Ventures, Mai Dun, Mercia and Mackay Ventures for purposes of Section 13(d) of the Exchange Act. Each Reporting Person disclaims beneficial ownership of such securities except to the extent of their pecuniary interest therein.
  • [F4]The securities are directly owned by Mai Dun, who is a member of a "group" with Roen Ventures, Mercia, Mackay Ventures and Mr. Mackay for purposes of Section 13(d) of the Exchange Act. Mackay Ventures, which is solely owned by Mr. Mackay, owns a 99% interest in each of Mai Dun and Mercia, and Mr. Mackay owns the remaining 1% interest in each of Mai Dun and Mercia. Mr. Mackay is deemed to possess shared voting and investment control over the securities held by Mai Dun, and may be deemed to have direct beneficial ownership of such securities. Each Reporting Person disclaims beneficial ownership of such securities except to the extent of their pecuniary interest therein.
  • [F5]The securities are directly owned by Mackay Ventures, who is a member of a "group" with Roen Ventures, Mai Dun, Mercia and Mr. Mackay for purposes of Section 13(d) of the Exchange Act. Mr. Mackay is the sole member and manager of Mackay Ventures, and may be deemed to possess sole voting and investment control over the securities held by Mackay Ventures, and may be deemed to have direct beneficial ownership of such securities. Each Reporting Person disclaims beneficial ownership of such securities except to the extent of their pecuniary interest therein.
  • [F6]Represents Mackay Ventures' 99% ownership interest in the securities held by each of Mai Dun and Mercia. Mr. Mackay is the sole member and manager of Mackay Ventures, and may be deemed to possess sole voting and investment control over the securities held by Mackay Ventures, and may be deemed to have direct beneficial ownership of such securities. Each Reporting Person disclaims beneficial ownership of such securities except to the extent of their pecuniary interest therein.
  • [F7]Represents Mr. Mackay's ownership interest in the securities held by each of Mai Dun, Mercia and Mackay Ventures. Mackay Ventures, which is solely owned by Mr. Mackay, owns a 99% interest in each of Mai Dun and Mercia, and Mr. Mackay owns the remaining 1% interest in each of Mai Dun and Mercia. Mr. Mackay is deemed to have shared voting and investment control over the securities held by each of Mai Dun, Mercia and Mackay Ventures, and may be deemed to have direct beneficial ownership of such securities. Each Reporting Person disclaims beneficial ownership of such securities except to the extent of their pecuniary interest therein.

Issuer

CV Sciences, Inc.

CIK 0001510964

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001510964

Filing Metadata

Form type
4
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 7:15 PM ET
Size
18.7 KB